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Background: Intermittent preventive treatment during pregnancy (IPTp) with optimal doses (two+) of
sulphadoxine-pyrimethamine (SP) protects pregnant women from malaria-related adverse outcomes. This study
assesses the extent and predictors of uptake of optimal doses of IPTp-SP in six districts of Tanzania.
Methods: The data come from a cross-sectional survey of random households conducted in six districts in Tanzania
in 2012. A total of 1,267 women, with children aged less than two years and who had sought antenatal care (ANC)
at least once during pregnancy, were selected for the current analysis. Data analysis involved the use of Chi-Square
(χ2) for associations and multivariate analysis was performed using multinomial logistic regression.
Results: Overall, 43.6% and 28.5% of the women received optimal (two+) and partial (one) doses of IPTp-SP respectively
during pregnancy. Having had been counseled on the dangers of malaria during pregnancy was the most pervasive
determinant of both optimal (RRR = 6.47, 95% CI 4.66-8.97) and partial (RRR = 4.24, 95% CI 3.00-6.00) uptake of IPTp-SP
doses. Early ANC initiation was associated with a higher likelihood of uptake of optimal doses of IPTp-SP (RRR = 2.05,
95% CI 1.18-3.57). Also, women with secondary or higher education were almost twice as likely as those who had never
been to school to have received optimal SP doses during pregnancy (RRR = 1.93, 95% CI 1.04-3.56). Being married was
associated with a 60% decline in the partial uptake of IPTp-SP (RRR = 0.40, 95% CI 0.17-0.96). Inter-district variations in the
uptake of both optimal and partial IPTp-SP doses existed (P < 0.05).
Conclusion: Counseling to pregnant women on the dangers of malaria in pregnancy and formal education beyond
primary school is important to enhance uptake of optimal doses of SP for malaria control in pregnancy in Tanzania. ANC
initiation in the first trimester should be promoted to enhance coverage of optimal doses of IPTp-SP. Programmes should
aim to curb geographical barriers due to place of residence to enhance optimal coverage of IPTp-SP in Tanzania.
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Malaria in pregnancy (MiP) exerts major public health
concerns worldwide, particularly in malaria-endemic set-
tings, and results in adverse health outcomes for both
woman and foetus [1,2]. Low birth weight (LBW), infant
mortality, maternal anaemia, spontaneous abortion, and
stillbirth are documented as devastating health conse-
quences of Plasmodium falciparum MiP [3]. About 11%* Correspondence: aexavery@ihi.or.tz
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stated.of neonatal mortality in malaria-endemic African coun-
tries is attributable to LBW that results from MiP [4]. In
sub-Saharan Africa, MiP reportedly accounts for 26% of
severe maternal anaemia [2] and up to 200,000 infant
mortality annually due to LBW [5,6]. Some 10,000 ma-
ternal deaths are recorded each year due to malaria-
related anaemia [5]. Against this, research has shown
that intermittent preventive treatment during pregnancy
(IPTp) with two doses of sulphadoxine-pyrimethamine
(SP) protects pregnant women from maternal anaemia
and malaria placental infection, and also reduces thel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
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that exposure to IPTp with SP (IPTp-SP) and insecticide-
treated bed nets (ITNs) are associated with reductions in
both neonatal mortality and LBW [7]. Under trial condi-
tions, IPTp-SP is acknowledged to be effective in reducing
neonatal mortality [8]. Recent evidence from Malawi re-
veals that IPTp-SP enhances birth outcomes [9].
The World Health Organization (WHO) recommends
IPTp-SP for all pregnant women at each schedule of
antenatal care (ANC), with the first dose administered
as early as possible during the second trimester of gesta-
tion, and that the subsequent dose be given at least one
month after the first. It is clarified further that the last
dose can be administered up to the time of delivery, with
no safety concerns [10]. SP is used for IPTp in many
sub-Saharan African countries [11]. In Tanzania where
neonatal mortality remains one of the challenging public
health concerns [3,12], the national policy stipulates
provision of SP to all pregnant women during ANC
visits [13], between 20 and 24 weeks’ gestation for the
first dose and between 28 and 32 weeks’ gestation for
the second dose to properly prevent malaria [14].
Several factors associated with incomplete coverage of
IPTp have been reported in previous studies. These in-
clude late ANC initiation [15,16], multigravidity [17] and
lack of knowledge of adverse consequences of MiP [18].
Systemic factors, namely, workforce shortage, inadequate
or erratic drug supply, poor skills of providers, and skewed
access to ANC services [15] have been identified as well.
One publication based on a nationally representative
household survey in Tanzania reported a decline between
2005 and 2007 for both IPTp-1 and IPTp-2: 71% versus
65% and 38% versus 30% respectively [19]. The study
found that urban residence was the only individual factor
associated with IPTp-2. The study however made its infer-
ences based on Chi-Square (χ2) tests, without involving
multivariate regression analysis to take care of confound-
ing. Another study estimated coverage of IPTp-1 and
IPTp-2 at 70 and 35%, respectively, in 2005/06 [20], but
did not identify factors affecting each. Generally, research
documentation of factors influencing both partial and op-
timal use of SP for malaria control in pregnancy is limited,
and even more so for the latter. It is further unknown
whether correlates for partial, and optimal use of SP are
similar or different.
Although the majority of women attend antenatal clinic
for ANC at least once during pregnancy, extant evidence
shows that IPTp-SP uptake as well as ITN coverage
among pregnant women is unacceptably low in most
countries [21], and lowest in areas with highest trans-
mission of malaria [22]. The Roll Back Malaria (RBM)
Summit, which was held in Abuja, Nigeria in 2000, tar-
geted 60% coverage of recommended MiP prevention
and treatment by 2005 [23,24], a target which was laterset to 80% by 2010 [25]. Although almost all pregnant
women in Tanzania receive ANC at least once and
43% at least four times [3], 66% of the women in
Tanzania mainland took anti-malarial drugs at least
one dose during pregnancy, and 27% took the recom-
mended (two or more) dosage of SP in 2010 [3]. This
reflects a major missed opportunity that warrants
analysis of factors that influence uptake, particularly
optimal uptake of IPTp-SP, in order to inform pro-
grammes and policies of underlying contexts that
should be observed to ensure universal and optimal
coverage of IPTp-SP. Also earlier studies have made
their inferences based on descriptive analyses with
limited use of such sophisticated methods of data
analysis as regressions. This study seeks to: (1) es-
timate the extent of IPTp-SP uptake as a proportion
of women that received one dose, and two or more
(two+) doses of SP during pregnancy; and, (2) con-
duct multivariate analysis using multinomial logit
model (polytomous logistic regression) to identify factors
affecting partial and optimal use of IPTp-SP among preg-
nant women in six districts (Geita, Kahama, Kondoa,
Mbozi, Singida and Sumbawanga) of Tanzania.
Methods
Data and area
The data for this study were collected in 2012 in
six Tanzanian rural districts namely Geita, Kahama,
Kondoa, Mbozi, Singida and Sumbawanga. The geograph-
ical locations of the districts, which are all malaria en-
demic, represent three of eight health zones as described
by the Tanzania Ministry of Health and Social Welfare.
The data were collected as part of a large cross-sectional
household survey to serve baseline purposes for the Em-
power II Project implemented by the Ifakara Health Insti-
tute, in Tanzania. The project seeks to improve maternal,
newborn and child health (MNCH) services for women of
reproductive age and children aged less than five years in
the stud area. It implements MNCH proven interventions
to demonstrate how best such interventions can be scaled
up across the country. Under the maternal component it
helps to build capacity of district health managers to ef-
fectively deliver maternal health services in the continuum
of care including malaria during pregnancy. Data collec-
tion tools were quantitative and there were field inter-
viewers to interview each of the respondents sampled.
Sampling for the survey was random and was imple-
mented using probability proportionate to size (PPS).
This method is used when sampling units (e.g. dis-
tricts, villages, etc.) are of different sizes in order to en-
sure that the resulting sample is representative of each
unit. Data entry was done in Microsoft Office Access
and latter transferred in STATA statistical software for
cleaning and analysis.
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Women who had children below the age of two years at
the time of the survey and had sought ANC at least once
during pregnancy were selected from the main database
for the current analysis. Having sought ANC at least
once was considered an important criterion because
questions pertaining to MiP and IPTp were administered
to women who did so.
Variables
The dependent or outcome variable for this study was
uptake of IPTp-SP. This was defined as the extent of SP
utilization for malaria control during pregnancy and was
derived from the question
“During pregnancy of (NAME OF CHILD), did you use
drugs (SP) to prevent malaria?”
If yes, “how many times?” Responses were grouped in
three categories such that:
Uptake of IPTp−SP ¼
NONE if no SP dose was
taken during pregnancy
PARTIAL if only one dose
of SP was taken during
pregnancy
OPTIMAL if two or more
2þð Þ doses of SP were taken
8>>>><
>>>>:
Independent variables included maternal age, marital
status, maternal education, maternal occupation and
district of residence. Others were whether a woman
was counseled on the dangers of malaria during preg-
nancy, number of ANC visits made, timing of ANC ini-
tiation, and pregnancy intentions.
Statistical analysis
The data were analysed both descriptively and analytically
using standard methods of applied statistics in public
health. Frequency distribution (one-way tabulations) of
participants across background characteristics was per-
formed first, then bivariate analysis was conducted, in
which the outcome variable, IPTp-SP uptake, was cross-
tabulated against each of the independent variables. The
degree of association between each pair of variables was
tested using Pearson’s Chi-Square (χ2) because all variables
were categorical. In this process, the degree of IPTp-SP
uptake was compared across categories of each of the in-
dependent variables. Where the test of association be-
tween the outcome and each of the independent variables
showed a P-value of 5% or less, the null hypothesis of no
association between the variables was rejected and conse-
quently concluded that they were significantly associated,
otherwise no association was deduced.The data were finally subjected to regression analysis
using multinomial logistic regresion in a multivariable way.
This was to ensure that variables were adjusted for one an-
other to obtain independent predictors of the IPTp-SP
uptake. The category ‘none’ of the outcome variable was
made a baseline/pivot outcome thus assessing what pre-
dicts partial, and complete receipt of IPTp-SP doses. Se-
lection of independent variables for the multivariate
models relied on each one’s ability to improve the over-
all model. This was achieved through the use of log-
likelihood ratio test. From the model outputs, relative
risk ratios (RRR), their corresponding 95% confidence
intervals (CI) and P-values were all presented. Signi-
ficance level was set at 5%. The whole process of data
analysis was conducted using STATA (version 11) statis-
tical software.
Ethical consideration
The primary study was approved by the Medical Re-
search Coordinating Committee (MRCC) of the National
Institute for Medical Research (NIMR) in Tanzania. Dur-
ing data collection, participation was voluntary, with po-
tential respondents having to sign an informed consent
form first. The interviewer read, and explained the con-
tent of the consent form to the potential respondent.
The respondent was also free to read the consent form
by herself and ask for clarifications concerning any as-
pect of the content. Then an interview followed only if
the respondent agreed and signed the consent form to
take part in the survey. The data were managed carefully
and remained anonymous throughout.
Results
Background characteristics
A total of 1,267 women who had children aged less than
two years and had sought ANC at least once during
pregnancy were analysed for the current question. Mean
age of the participants was 27.2 ±7.4 years, ranging from
15 to 50. The majority of women (90%) were married
and about 70% of the women had a primary education.
Occupationally, a majority of the women (72%) were
farmers or livestock keepers. With respect to district of
residence, 15.6% of the women resided in Geita, 29.0%
resided in Kahama, 17.1% resided in Kondoa, 22.1% re-
sided in Mbozi, 6.5% resided in Singida and 9.6% resided
in Sumbawanga (Table 1).
Bivariate analysis
Table 2 displays percentage distribution of IPTp-SP uptake
by characteristics of respondents. Overall, 43.6 and 28.5%
of the women received complete and partial doses of SP, re-
spectively, during pregnancy. This was equivalent to 72.1%
coverage of IPTp-SP of at least one dose. These proportions
were significantly influenced by various characteristics.
Table 1 Profile of respondents







Currently married 1,152 90.9
Ever married 50 4.0
Single 65 5.1
Education




Farmer/livestock keeper 909 71.7
Employed/self-employed 165 13.0
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highest among women who were counseled on the
dangers of MiP in comparison of those who were not
counseled, 31.7% versus 20.7% and 51.7% versus 23.7%
respectively (P <0.001).
Timing of ANC initiation was significantly important
in determining the extent of IPTp-SP uptake (P = 0.015).
Uptake of optimal doses of IPTp-SP was highest among
women who initiated ANC in the first trimester of preg-
nancy and lowest among those who initiated ANC in the
third trimester (46.4% versus 36.5%). Similarly, women
who had sought ANC at least four times in the course of
pregnancy were more likely than those who received
ANC less than four times to receive optimal doses of
IPTp-SP (47.6 against 39.9%). In contrast, receipt of par-
tial IPTp-SP doses was higher among women who re-
ceived ANC less than four times than that observed
among women who had sought ANC at least four times
during pregnancy (31.5 against 25.1%) (P = 0.011).
In terms of marital status, receipt of complete IPTp-SP
doses was highest among women who were single (52.3%),
whereas partial IPTp-SP doses became lowest at 16.0%
among those ever married (P = 0.015). With regard toeducation, uptake of IPTp-SP increased with education,
from as low as 38.9% among those who had no education
to as high as 52.3% among those with secondary and higher
education. There was no clear pattern of uptake of partial
IPTp-SP doses, but was highest at 30.4% among women
that had primary education (P <0.001). Other factors asso-
ciated with IPTp-SP uptake were occupation (P = 0.040)
and district of residence (P <0.001), whereby partial uptake
of IPTp-SP ranged from 13.9% in Sumbawanga to 39.6% in
Mbozi, and optimal uptake of IPTp-SP ranged from 34.9%
in Geita to 54.4% in Kahama district.
Multivariate analysis
Table 3 presents findings from the multivariate multinomial
(polytomous) logistic regression models of factors associ-
ated with complete and partial uptake of IPTp-SP in the
study area. Having had been counseled on dangers of MiP
was the most pervasive determinant of both complete and
partial uptake of IPTp-SP. The relative risk of receiving
complete IPTp-SP doses was significantly 6.47 times higher
among women who were counseled on dangers of MiP
than that observed among women who were not counseled
(RRR = 6.47, 95% CI 4.66-8.97). Likewise, receipt of partial
IPTp-SP doses was 4.24 times more likely among women
counseled on dangers of MiP than women not counseled
(RRR = 4.24, 95% CI 3.00-6.00). Receipt of complete IPTp-
SP doses was two-fold more likely among women that initi-
ated ANC in the first trimester compared to women that
initiated ANC in the third trimester (RRR = 2.05, 95% CI
1.18-3.57).
Marital status was a significant predictor of partial
IPTp-SP uptake, such that women who were ever mar-
ried (currently divorced or widowed) were 60% less likely
than those currently married to receive partial IPTp-SP
(RRR = 0.40, 95% CI 0.17-0.96).
Education was also a significant predictor of optimal
but not partial IPTp-SP uptake. Women with secondary
and higher education were almost twice as likely as
those who had had never been to school for formal edu-
cation to receive complete IPTp-SP doses (RRR = 1.93,
95% CI 1.04-3.56).
Regarding district of residence, its effect was mostly
on partial uptake of IPTp-SP, whereby the likelihood of
uptake of partial IPTp-SP doses was significantly higher
in Kahama (RRR = 3.26, 95% CI 1.91-5.55), Kondoa
(RRR= 2.11, 95% CI 1.20-3.70), Mbozi (RRR= 2.63, 95% CI
1.54-4.51), and Singida (RRR= 2.86, 95% CI 1.39-5.91) than
in Geita. Sumbawanga had less chance for partial
IPTp-SP uptake compared to Geita, but the effect was
not statistically significant (P >0.05). The district effect
on receipt of complete doses of IPTp-SP was 3.26
times higher in Kahama compared to Geita (RRR =
3.26, 95% CI 2.03-5.23). The rest of the districts had
higher chances for complete IPTp-SP doses compared to




None Partial (1 dose) Optimal (2+ doses)
OVERALL 1,267 27.9 28.5 43.6 -
Counseled on dangers of MiP
No 367 55.6 20.7 23.7
<0.001
Yes 900 16.7 31.7 51.7
Timing of ANC initiation
First trimester 222 20.3 33.3 46.4
0.015Second trimester 856 29.0 26.6 44.4
Third trimester 189 32.3 31.2 36.5
Number of ANC visits made
1-3 666 28.5 31.5 39.9
0.011
4+ 601 27.3 25.1 47.6
Pregnancy intention
Unintended/don’t remember 368 31.3 26.4 42.4
0.220
Intended 899 26.6 29.4 44.1
Age (years)
<20 132 33.3 24.2 42.4
0.49420-34 909 27.4 28.4 44.2
>34 226 27.0 31.4 41.6
Marital status
Currently married 1,152 27.2 29.5 43.3
0.015Ever married 50 46.0 16.0 38.0
Single 65 27.7 20.0 52.3
Education
No education 226 38.5 22.6 38.9
<0.001Primary 879 27.4 30.4 42.2
Secondary+ 162 16.1 26.5 57.4
Occupation
Farmer/livestock keeper 909 29.4 28.9 41.7
0.040Employed/self-employed 165 18.8 28.5 52.7
No job/housewife 193 29.0 26.4 44.6
District
Geita 198 46.5 18.7 34.9
<0.001
Kahama 368 18.2 27.5 54.4
Kondoa 217 26.3 30.0 43.8
Mbozi 280 22.1 39.6 38.2
Singida 82 24.4 36.6 39.0
Sumbawanga 122 45.9 13.9 40.2
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(P >0.05).
Discussion
This study assessed the extent and factors affecting the
uptake of both partial and optimal IPTp-SP doses amongwomen during pregnancy in Geita, Kahama, Kondoa,
Mbozi, Singida and Sumbawanga districts of Tanzania.
Overall 43.6% of the women in the study area received op-
timal (two+) IPTp-SP doses during pregnancy. The rest,
28.5 and 27.9%, received partial (only one dose) and none
of the SP doses, respectively. Therefore IPTp-SP coverage
Table 3 Multivariate multinomial logistic regression models of correlates of IPTp-SP uptake in six districts of
Tanzania, (n = 1,267)
IPTp-SP uptake
Variable









Counseled on dangers of MiP
No (ref) 1.00 - 1.00 -
Yes 4.24*** 3.00-6.00 6.47*** 4.66-8.97
Timing of ANC initiation
First trimester 1.66* 0.94-2.94 2.05** 1.18-3.57
Second trimester 1.03 0.66-1.59 1.50* 0.98-2.29
Third trimester (ref) 1.00 - 1.00 -
Age (years)
<20 (ref) 1.00 - 1.00 -
20-34 1.40 0.82-2.40 1.34 0.83-2.17
>34 1.50 0.80-2.80 1.29 0.73-2.20
Marital status
Currently married (ref) 1.00 - 1.00 -
Ever married 0.40** 0.17-0.96 0.60 0.30-1.22
Single 0.51* 0.23-1.11 0.83 0.42-1.60
Education
No education (ref) 1.00 - 1.00 -
Primary 1.22 0.78-1.89 1.17 0.79-1.74
Secondary+ 1.44 0.73-2.83 1.93** 1.04-3.56
Occupation
Farmer/livestock keeper 1.00 - 1.00 -
Employed/self-employed 0.98 0.57-1.71 1.03 0.62-1.74
No job/housewife 0.79 0.49-1.26 0.83 0.54-1.28
District
Geita (ref) 1.00 - 1.00 -
Kahama 3.26*** 1.91-5.55 3.26*** 2.03-5.23
Kondoa 2.11** 1.20-3.70 1.55* 0.93-2.58
Mbozi 2.63*** 1.54-4.51 1.25 0.76-2.06
Singida 2.86** 1.39-5.91 1.62 0.80-3.25
Sumbawanga 0.66 0.32-1.33 1.00 0.57-1.74
***P<0.001, **P<0.050, *P<0.100; ref = reference/baseline category.
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higher than the national estimates from the 2010 Tanzania
DHS report [3], reflecting geographical variations in the
coverage of IPTp-SP in Tanzania. The survey reported
66.0% coverage of at least one dose (IPTp-1) and 27.0%
for the recommended dosage (IPTp-2) [3]. These findings
reveal an outstanding failure to meet the RBM target of
80% coverage of the recommended IPTp-SP dosage by
2010 [25]. This is an important missed opportunity, espe-
cially for women who received only one dose of IPTp-SP,meriting the need to understand why some women that
receive one dose do not take the second. The understand-
ing of what it would take to ensure that pregnant women
who take the first dose of SP also take the second, and
non-users initiate and sustain the dosage is crucial.
Several factors associated with both partial and opti-
mal use of SP for malaria control in pregnancy were
identified. Having had been counseled on the dangers of
MiP was the strongest factor determining both optimal
and partial uptake of IPTp-SP in the study area. The
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higher than that for partial IPTp-SP. Likewise, education
beyond primary school (i.e. secondary or higher) showed
a remarkable influence on the optimal use of SP for ma-
laria control in pregnancy, but had no significant effect
on IPTp-1. Unfortunately, no similar or dissimilar fin-
dings were found in the literature linking counseling on
the dangers of MiP during pregnancy and uptake of SP
for IPTp. Creating and promoting awareness of the
women, and probably the general public, on the dangers
of MiP can potentially improve the uptake of optimal
doses of SP and ultimately enhance health outcomes.
Improving health services to enable, among others, bet-
ter counseling services to pregnant women on the dan-
gers of MiP could attract more women to take optimal
doses of SP for the control of MiP. This goes together
with a need to support women’s formal education be-
yond primary school to ensure autonomy and emancipa-
tion against restrictive cultures or lack of information
that directly or indirectly retards access to better health
care. Education is known to play a transformational role
and stands as a catalyst for change that informs and in-
fluences decisions and choices [26,27].
This study observed that ANC initiation in the first tri-
mester (proper timing) was significantly associated with
uptake of optimal doses of IPTp-SP. The number of ANC
visits made during pregnancy showed no important effect,
suggesting that the quality of ANC counts more than just
the quantity of visits. This means that the earlier a preg-
nant woman initiates ANC the more the time she has to
be counseled on the dangers of MiP and the use of SP and
other interventions such as mosquito bed nets [3,28]. This
underscores the need to promote timely initiation of ANC
among pregnant women in order to increase their chances
for uptake of MiP interventions and subsequently avert
malaria-related health outcomes. Beyond optimal use of
SP for malaria control in pregnancy, timing of ANC initia-
tions is associated with other important health outcomes
[29-32]. As ANC remains largely a facility-based health
care, the observation corroborates earlier findings about
the imperative role of the health system in accelerating
uptake of interventions, including SP against MiP [15],
thus calling attention to strengthening the health system
in such aspects as workforce sufficiency, skills, availability
of equipments and supplies [15].
Between-district variations in the likelihood of partial
and optimal use of IPTp-SP for malaria control in preg-
nancy were observed. Geographical factors, such as place
of residence, have been acknowledged in other studies as
important drivers or barriers to distribution, access and
utilization of various health services [33,34]. While it is
possible that factors that influence uptake of IPTp-SP
may be inequitably distributed between the districts due
to different contexts, it may as well be an indicator ofhow MiP interventions have penetrated the districts dif-
ferently. It is also possible that some districts may be
more rural or more urban than others as it is already doc-
umented that urban residence is associated with uptake of
IPTp-SP. Therefore, programmes aimed at enhancing op-
timal use of IPTp-SP should fully account for area-specific
contexts for better coverage and health outcomes.
Lastly, marital status was significantly associated with
partial but not optimal use of IPTp-SP, whereby ever
married women (currently divorced or widowed) were
less likely than currently married women to have taken
partial IPTp-SP doses. It is possible that married women
have the advantage of discussing, planning and making
decisions on their health matters with their spouses,
which can encourage uptake of IPTp-SP. Some studies
have shown a positive association between presence of
inter-spousal discussion about health matters, such as
family planning and utilization of various health ser-
vices [35-37]. Therefore, women who are not married
may have limited opportunity for discussions and deci-
sions on health issues. However, further investigation is
needed to find out the underlying mechanisms of this
relationship.
Counseling on dangers of MiP and district of residence
affected both partial and optimal use of IPTp-SP. While
education affected only optimal use of IPTp-SP, marital
status did so only on partial uptake of IPTp-SP. The effect
of timing of ANC initiation was more pronounced for op-
timal IPTp-SP. Both occupation and maternal age had no
significant effect on both partial and optimal IPTp-SP.Limitations
Some variables such as gravidity or fertility, rural/urban
residence, religion, and socio-economic status of the re-
spondents were not available for inclusion. Also infor-
mation or recall bias may have happened because the
data were based on interview only, as well as the two
years delay within which the respondents may have had
forgotten some details. No causal inferences may be
drawn from these findings because of snapshot nature of
cross-sectional studies.Conclusion
Optimal coverage of IPTp-SP of 44% in the study area
could possibly increase to as high as 72% if sustainability
was guaranteed for women who took only one dose. Im-
proving health services especially ANC to ensure better
counseling services on the dangers of MiP to pregnant
women, proper timing of ANC initiation, formal educa-
tion beyond primary school are necessary for enhanced
coverage of IPTp-SP and consequently better health out-
comes of pregnant women and their newborns in the
study area.
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tative in nature are needed to elucidate any underlying
social perceptions, beliefs, and prevention or treatment
means of MiP. It is also important to understand why
women who take only one dose of IPTp-SP do not take
the second as recommended. This will divulge reasons for
low coverage of optimal IPTp-SP. There might be some
misconceptions concerning MiP interventions which may
result in changing patterns of health care seeking modal-
ities during pregnancy and consequently affect uptake of
SP for IPTp.
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